|
|
| MRD / Regn No. |
: SG004696 |
Date |
: 23/07/2026 |
| Patient Name |
: Ashiayan Khan |
Age & Gender |
: 37 Yrs. / Female |
| Contact No. |
: 9830188970 |
UHID |
: |
| Ht / Wt / BMI |
: 166 / 80 / 29.03 |
BP S / BP D |
: 129 / 84 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (23/Jul/2026) | HYPOTHYROIDISM (23/Jul/2025) | HYPERTENSION (23/Jul/2026) | |
| Salient Investigations |
: |
CREATININE: 0.5 | EGFR EGLOMERULAR FILTRATION RATE: 148.43 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 151 mg/dL | HB HEMOGLOBIN: 11.3 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 7 % | POST PRANDIAL GLUCOSE (2HPP): 197 mg/dL | TSH THYROID STIMULATING HORMONE: 3.7 mIU/L | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET TELMISARTAN 40 MG + ATORVASTATIN 10 MG
ARBITEL AV
Medicine For PO |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
2 |
TABLET THYROXINE 75 MCG
THYRONORM 75 MCG
Medicine For HYPOTHYROIDISM |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
| MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR BREAKFAST MUST BE TAKEN ONLY AFTER 30 MINUTES. OTHER DRUGS CAN INTERFERE WITH THE ABSORPTION OF THYROXINE | |
|
3 |
ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + METFORMIN SR 500 MG
APDA M 500 MG |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 23/Jan/2027 |
| Tests Suggested For Next Visit |
: HBA1C-HPLC METHOD,CREATININE |
| |
|
| |
|
